Compare NAVI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAVI | PLSE |
|---|---|---|
| Founded | 1973 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | NAVI | PLSE |
|---|---|---|
| Price | $8.63 | $18.02 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $12.14 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.0M | 501.8K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 7.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $82.46 | $883.71 |
| Revenue Next Year | $12.45 | $225.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.36 | $12.56 |
| 52 Week High | $16.07 | $26.30 |
| Indicator | NAVI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 22.71 | 46.17 |
| Support Level | N/A | $13.75 |
| Resistance Level | $13.34 | $18.11 |
| Average True Range (ATR) | 0.34 | 1.73 |
| MACD | 0.01 | -0.72 |
| Stochastic Oscillator | 16.00 | 7.24 |
Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in three segments: Federal Education Loans, Consumer Lending, and Business Processing. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.